Octreotide long acting release for severe obscure gastrointestinal haemorrhage in elderly patients with serious comorbidities;Octreótido long acting release para la hemorragia digestiva en pacientes de edad avanzada con comorbilidad

Medicina Clinica

Volumn 133, Issue 17, 2009, Pages 667-670

  Molina Infante, Javier ^a   Pérez Gallardo, Belén ^a   Hernández Alonso, Moisés ^a   Mateos Rodríguez, José María ^a   Dueñas Sadornil, Carmen ^a   Fernández Bermejo, Miguel ^a  

^a HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

Author keywords

Anticoagulants; Comorbidity; Gastrointestinal haemorrhage; Octreotide; Octreotide long acting release

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HEMOGLOBIN; OCTREOTIDE;

ABSENCE OF SIDE EFFECTS; AGED; AGING; ANGIODYSPLASIA; ARTICLE; BILIARY TRACT DISEASE; BLOOD TRANSFUSION; CHOLELITHIASIS; CLINICAL ARTICLE; COMORBIDITY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG RELEASE; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MALE; OBSCURE GASTROINTESTINAL HEMORRHAGE; SMALL INTESTINE ANGIODYSPLASIA; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; DELAYED-ACTION PREPARATIONS; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; OCTREOTIDE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VASOCONSTRICTOR AGENTS;

EID: 70350567738     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2009.07.013     Document Type: Article

References (10)

1. J. Molina Infante, B. Pérez Gallardo, and M. Fernández Bermejo Avances en el tratamiento farmacológico de la hemorragia digestiva de origen oscuro Rev Esp Enferm Dig 99 2007 457 462
2. G. Nardone, A. Rocco, T. Balzano, and G. Budillon The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract Aliment Pharmacol Ther 13 1999 1429 1436
3. F. Junquera, S. Saperas, S. Videla, F. Feu, J. Vilaseca, J.R.A. Armengol, et al. Long-term efficacy of octreotide in the prevention of recurrent bleeding from gastrointestinal angiodysplasia Am J Gastroenterol 102 2007 254 260
4. L. Spahr, E. Giostra, J.L. Frossard, I. Morard, G. Mentha, and A. Hadengue A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: A randomized controlled study Am J Gastroenterol 102 2007 1397 1405
5. P. Orsi, C. Guatti-Zuliani, and L. Okolicsanyi Long-acting octreotide is effective in controlling rebleeding angiodysplasia of the gastrointestinal tract Dig Liver Dis 33 2001 330 334
6. G. Tamagno, R. Mioni, E. De Carlo, P. Maffei, D. Rubello, and N. Sicolo Effects of a somatostatin analogue in occult gastrointestinal bleeding: A case report Dig Liver Dis 36 2004 843 846
7. N. Krikis, K. Tziolamos, V. Perifanis, S. Vakalopoulou, A. Karagiannis, V. Garipidou, et al. Treatment of recurrent gastrointestinal haemorrhage in a patient with von Willebrand's disease with octreotide LAR and propanolol Gut 54 2005 171 172
8. J. Molina Infante, B. Perez Gallardo, G. González García, M. Fernández Bermejo, J.M. Mateos Rodríguez, and P. Robledo Andrés Octreotide LAR for severe obscure-overt gastrointestinal haemorrhage in high-risk patients on anticoagulation therapy Gut 56 2007 447
9. L. Boesby, N.J. Christensen, and L.O. Kristensen Somatostatin analogues in the treatment of bleeding GI-angiodysplasias Ugeskr Laeger 170 2008 958
10. G Scaglione, L Pietrini, F Russo, MR Franco, and I. Sorrentini Long-acting octreotide as rescue therapy in chronic bleeding from gastrointestinal angiodysplasia Aliment Pharmacol Ther 26 2007 935 942